From July 1, 2023 to September 30, 2023, the company has repurchased 861,800 shares, representing 2.36% for ¥2,762.72 million. With this, the company has completed the repurchase of 910,200 shares, representing 2.49% for ¥2,927.18 million under the buyback announced on May 15, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,055 JPY | -2.08% | -4.68% | -6.57% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.57% | 708M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.